Jiujie Yang
Macau, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Corrigendum to "TREX1 activators: A novel therapeutic strategy for rheumatoid arthritis management via cfDNA clearance" [Pharmacol. Res. 218 (2025) 107817].
Journal: Pharmacological research
Published: January 13, 2026
High-throughput RNA sequencing identifies hub genes and anti-inflammatory effects of β-caryophyllene in cerebral ischemia-reperfusion via p38MAPK/NF-κB modulation.
Journal: Brain research bulletin
Published: November 26, 2025
TREX1 activators: A novel therapeutic strategy for rheumatoid arthritis management via cfDNA clearance.
Journal: Pharmacological research
Published: April 18, 2025
Anxiolytic effects of corilagin by targeting Htr2c through activation of the TrkB/CREB/BDNF pathway.
Anxiolytic effects of corilagin by targeting Htr2c through activation of the TrkB/CREB/BDNF pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 09, 2025
Celastrol derivatives ameliorate arthritis in AIA rats via modulating calcium signaling.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 12, 2024
N-Acetylcysteine overcomes epalrestat-mediated increase of toxic 4-hydroxy-2-nonenal and potentiates the anti-arthritic effect of epalrestat in AIA model.
Journal: International journal of biological sciences
Published: April 06, 2023
Mutant p53R211* ameliorates inflammatory arthritis in AIA rats via inhibition of TBK1-IRF3 innate immune response.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: March 10, 2023
The role of non-coding RNAs (miRNA and lncRNA) in the clinical management of rheumatoid arthritis.
Journal: Pharmacological research
Published: August 02, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026